You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

temodar refractory

Showing 1 - 25 of 8,878
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)

Active, not recruiting
  • Malignant Supratentorial Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2021

Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)

Recruiting
  • Relapsed Neuroblastoma
  • Refractory Neuroblastoma
  • Natural Killer Cells
  • +4 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Oct 26, 2022

Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Jun 17, 2022

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

Active, not recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Refractory Extensive Stage Small Cell Lung Carcinoma
  • Bakersfield, California
  • +5 more
Jan 5, 2023

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Neuroblastoma Trial in United States (TPI 287, Temozolomide, Irinotecan)

Terminated
Has Results
  • Neuroblastoma
  • TPI 287
  • +2 more
  • Phoenix, Arizona
  • +7 more
Apr 20, 2022

Solid Tumors, Primary Brain Tumors Trial in United States (Vincristine, Irinotecan, Temozolomide)

Completed
  • Solid Tumors
  • Primary Brain Tumors
  • Hartford, Connecticut
  • +13 more
Jan 12, 2023

Recurrent Lymphoma, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan,

Active, not recruiting
Has Results
  • Recurrent Lymphoma
  • +5 more
  • Birmingham, Alabama
  • +19 more
Oct 20, 2022

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan

Active, not recruiting
  • Childhood Solid Neoplasm
  • +4 more
  • Irinotecan Hydrochloride
  • +4 more
  • Birmingham, Alabama
  • +20 more
Feb 1, 2023

Solid Tumor Trial in Cincinnati (Bevacizumab, Temozolomide, Vincristine)

Completed
  • Solid Tumor
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Feb 8, 2021

Childhood Solid Tumors Trial in Memphis (Talazoparib, Irinotecan, Temozolomide)

Completed
  • Childhood Solid Tumors
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Feb 8, 2021

Adult Solid Tumor, Childhood Solid Tumor, Recurrent Childhood CNS Tumor Trial in United States (Laboratory Biomarker Analysis,

Completed
Has Results
  • Adult Solid Neoplasm
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +21 more
Mar 1, 2021

Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor Trial in Worldwide (Palbociclib, Temozolomide, Irinotecan)

Recruiting
  • Ewing Sarcoma
  • +6 more
  • Birmingham, Alabama
  • +83 more
Aug 19, 2022

High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine

Recruiting
  • High Risk Neuroblastoma
  • +2 more
  • Dinutuximab
  • +4 more
  • Birmingham, Alabama
  • +141 more
Dec 28, 2022

Glioma, Rhabdomyosarcoma, Osteosarcoma Trial (Erlotinib, Temozolomide)

Withdrawn
  • Glioma
  • +7 more
  • (no location specified)
Sep 5, 2019

Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Bevacizumab)

Completed
  • Glioblastoma Multiforme
  • +3 more
  • Castro Valley, California
  • +16 more
May 26, 2020

Glioblastoma Trial in United States (Temozolomide, Neratinib, QBS10072S)

Active, not recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +11 more
Aug 15, 2022

Ewing Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in United States (Vigil, Irinotecan, Temozolomide)

Active, not recruiting
  • Ewing Sarcoma
  • +12 more
  • Vigil
  • +2 more
  • Little Rock, Arkansas
  • +16 more
Feb 9, 2022

Efficacy and Safety Trial in Jinan (apatinib, temodar)

Completed
  • Efficacy and Safety
  • Jinan, Shandong, China
    Neurosurgery, Shandong Cancer Hospital and Institute
Apr 14, 2019

Recurrent Small Cell Lung Carcinoma Trial in United States (Laboratory Biomarker Analysis, Placebo, Temozolomide)

Completed
Has Results
  • Recurrent Small Cell Lung Carcinoma
  • Laboratory Biomarker Analysis
  • +3 more
  • Tampa, Florida
  • +9 more
Oct 28, 2019

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Glioblastoma, Recurrent Glioblastoma Trial in Boston (Pembrolizumab, Olaparib, Temozolomide)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Boston, Massachusetts
  • +2 more
Jul 14, 2022

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
Has Results
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Childhood CNS Tumor Trial in Washington (genetic, radiation, drug)

Not yet recruiting
  • Childhood CNS Tumor
  • SGT-53
  • +4 more
  • Washington, District of Columbia
    Children's National Medical Center
Feb 7, 2022